SVB capital crunch sends biotechs on bank run March 10, 2023 7:44 am https://www.fiercebiotech.com/biotech/biotech-bank-svbs-capital-crunch-sparks-bank-run-companies-huddle-consider-exposure

Vertex's next off-the-shelf diabetes cell therapy follows in predecessor's footsteps to the clinic March 9, 2023 6:10 am https://www.fiercebiotech.com/biotech/vertexs-next-shelf-diabetes-cell-therapy-follows-predecessors-footsteps-clinic

Protagonist's story turns for the better as J&J-partnered psoriasis med clears lesions in midphase trial March 7, 2023 5:57 am https://www.fiercebiotech.com/biotech/protagonists-story-takes-turn-better-jj-partnered-psoriasis-med-clears-lesions-midphase

To 'keep pace with viral evolution,' Invivyd is also evolving (again) March 6, 2023 6:16 am https://www.fiercebiotech.com/biotech/keep-pace-viral-evolution-invivyd-also-evolving-again

Novartis ready to head for deep space with Voyager after a year 'kicking the tires' March 3, 2023 10:50 am https://www.fiercebiotech.com/biotech/novartis-ready-head-deep-space-voyager-after-year-kicking-tires

Confo hands baton to Lilly for non-opioids pain med development in $40M upfront deal March 1, 2023 11:34 am https://www.fiercebiotech.com/biotech/confo-hands-baton-lilly-non-opioids-pain-med-development

New Ambrx CEO spies path for ousted breast cancer med as partner posts encouraging phase 2 results March 1, 2023 6:37 am https://www.fiercebiotech.com/biotech/new-ambrx-ceo-spies-path-forward-ousted-breast-cancer-med-partner-posts-encouraging-phase-2

Alzheimer's meds are here. But for the Down syndrome community, it's still the 1980s February 28, 2023 8:56 am https://www.fiercebiotech.com/biotech/down-syndrome-and-alzheimers-pharma-clinical-trials-safety-lecanemab

FDA flags Guillain-Barré risks for GSK, Pfizer RSV shots, but just one will need safety trial February 28, 2023 6:17 am https://www.fiercebiotech.com/biotech/fda-flags-guillain-barre-syndrome-risks-gsk-pfizer-rsk-vaccines-just-one-will-need-post

Theravance takes another blow, but vows to fight on with slimmed headcount and new trial February 27, 2023 4:51 pm https://www.fiercebiotech.com/biotech/theravance-takes-another-blow-vows-fight-slimmed-headcount-and-new-trial